Bio Absorbable Sirolimus-eluting Coronary Stent (SES)

On March 5, 2020, NMPA has granted the registration certificate of Bio Absorbable Sirolimus-eluting Coronary Stent (SES) from Shandong AWA Biopharm Co. Ltd. Compared with traditional metal drug stents, this product has more advantages, e.g., the final degradation products of the stent are water and carbon dioxide to reduce late thrombosis. Bradynuoen has extensive experiences in cardiovascular registration and clinical trial. Please feel free to let us know any challenges for China entry. info@inspirativemed.com

Link: http://www.nmpa.gov.cn/WS04/CL2056/375297.html